Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma

20Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Nasopharyngeal carcinoma (NPC) is a malignant tumor of the head and neck. The primary clinical manifestations are nasal congestion, blood-stained nasal discharge, headache, and hearing loss. It occurs frequently in Southeast Asia, North Africa, and especially in southern China. Radiotherapy is the main treatment, and currently, imaging examinations used for the diagnosis, treatment, and prognosis of NPC include computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)-CT, and PET-MRI. These methods play an important role in target delineation, radiotherapy planning design, dose evaluation, and outcome prediction. However, the anatomical and metabolic information obtained at the macro level of images may not meet the increasing accuracy required for radiotherapy. As a technology used for mining deep image information, radiomics can provide further information for the diagnosis and treatment of NPC and promote individualized precision radiotherapy in the future. This paper reviews the application of radiomics in the diagnosis and treatment of nasopharyngeal carcinoma.

Cite

CITATION STYLE

APA

Zhang, Y. M., Gong, G. Z., Qiu, Q. T., Han, Y. W., Lu, H. M., & Yin, Y. (2022, January 5). Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.767134

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free